These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 37492424)

  • 1. Acceptance of and hesitancy about COVID-19 vaccination among nursing students in clinical practice.
    Kim S; Lee J; Yang H; Kim H
    PLoS One; 2023; 18(7):e0286640. PubMed ID: 37494378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the perceptions and experiences of mobile teams on COVID-19 vaccine uptake at the community level: evidence from Benue and Niger states.
    Isiaka SD; Jimoh AU; Samuel OW; Atobatele S; Sampson S; David JC; Okoye I; Adegoke Z; Daniel V; Nto S
    BMC Public Health; 2024 Jul; 24(1):1996. PubMed ID: 39061021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised experimental evaluation of a social media campaign to promote COVID-19 vaccination in Nigeria.
    Evans WD; Bingenheimer JB; Long MW; Ndiaye K; Donati D; Rao NM; Akaba S; Agha S
    J Glob Health; 2024 May; 14():05018. PubMed ID: 38779876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge, attitudes and demographic drivers for COVID-19 vaccine hesitancy in Malawi.
    Ndasauka Y; Twabi HS; Kainja J; Gunde AM; Makhumula-Mtimuni C
    Sci Rep; 2024 Apr; 14(1):9578. PubMed ID: 38671014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognizance and mitigation of falsified immunization documentation: Analyzing the consequences for public health in Nigeria, with a focus on counterfeited COVID-19 vaccination cards: A case report.
    Ali VE; Asika MO; Elebesunu EE; Agbo C; Antwi MH
    Health Sci Rep; 2024 Feb; 7(2):e1885. PubMed ID: 38410502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative Synthesis of Factors Associated with COVID-19 Vaccine Acceptance and Vaccine Hesitancy in 185 Countries.
    Dinga JN; Kabakama S; Njimoh DL; Chia JE; Morhason-Bello I; Lumu I
    Vaccines (Basel); 2023 Dec; 12(1):. PubMed ID: 38250847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing COVID-19 vaccine hesitancy and improving vaccine uptake in Nigeria.
    Eguavoen A; Larson HJ; Chinye-Nwoko F; Ojeniyi T
    J Public Health Afr; 2023 Apr; 14(5):2290. PubMed ID: 37492424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 Vaccine Hesitancy and Trust in Government in Nigeria.
    Sato R
    Vaccines (Basel); 2022 Jun; 10(7):. PubMed ID: 35891171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 Vaccine Hesitancy in a Medically-Challenged Context: A Cross-Sectional Study of Drivers, Dangers and Corrective Measures for Vaccine Hesitancy and Potential Penalties for Declining Vaccination among Adults in South-Eastern Nigeria.
    Iloh GU; Chukwuonye ME
    West Afr J Med; 2022 Sep; 39(9):889-895. PubMed ID: 36116070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 vaccine hesitancy: a systematic review of barriers to the uptake of COVID-19 vaccine among adults in Nigeria.
    Babatope T; Ilyenkova V; Marais D
    Bull Natl Res Cent; 2023; 47(1):45. PubMed ID: 36970323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine hesitancy against COVID-19 vaccine over time in Nigeria.
    Sato R
    Vaccine; 2023 Apr; 41(17):2749-2753. PubMed ID: 36959055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conspiracy theories and misinformation about COVID-19 in Nigeria: Implications for vaccine demand generation communications.
    Wonodi C; Obi-Jeff C; Adewumi F; Keluo-Udeke SC; Gur-Arie R; Krubiner C; Jaffe EF; Bamiduro T; Karron R; Faden R
    Vaccine; 2022 Mar; 40(13):2114-2121. PubMed ID: 35153088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Global Map of COVID-19 Vaccine Acceptance Rates per Country: An Updated Concise Narrative Review.
    Sallam M; Al-Sanafi M; Sallam M
    J Multidiscip Healthc; 2022; 15():21-45. PubMed ID: 35046661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tracking the uptake and trajectory of COVID-19 vaccination coverage in 15 West African countries: an interim analysis.
    Afolabi MO; Wariri O; Saidu Y; Otu A; Omoleke SA; Ebenso B; Adebiyi A; Ooko M; Ahinkorah BO; Ameyaw EK; Seidu AA; Agogo E; Nomhwange T; Salami K; Mohammed NI; Yaya S
    BMJ Glob Health; 2021 Dec; 6(12):. PubMed ID: 34906987
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.